• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国临床分离株和非结核分枝杆菌参考株对 41 种药物的药敏性和 MIC 分布。

Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.

机构信息

State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; Immunology Department, Changzhi Medical College, Shanxi 046000, China.

出版信息

Int J Antimicrob Agents. 2017 Mar;49(3):364-374. doi: 10.1016/j.ijantimicag.2016.10.024. Epub 2016 Dec 21.

DOI:10.1016/j.ijantimicag.2016.10.024
PMID:28131606
Abstract

To treat nontuberculous mycobacteria (NTM) infections more optimally, further research pertaining to mycobacterial susceptibility to antimicrobial agents is required. A total of 82 species of NTM reference strains and 23 species of NTM clinical isolates were included. Minimum inhibitory concentrations (MICs) for 41 drugs were determined using the microdilution method in cation-adjusted Mueller-Hinton broth. The results showed that most of the NTM were susceptible to aminoglycosides, quinolones, three macrolides (clarithromycin, azithromycin and roxithromycin), cefmetazole, linezolid and capreomycin. Rapidly growing mycobacterium strains were additionally susceptible to cefoxitin, clofazimine, rifapentine, doxycycline, minocycline, tigecycline, meropenem and sulfamethoxazole, whereas slowly growing mycobacterium strains were additionally susceptible to rifabutin. This study on the susceptibility of NTM includes the largest sample size of Chinese clinical isolates and reference strains. NTM species-specific drug susceptibility patterns suggested that it is urgent to identify the species of NTM, to normalise the treatment of NTM infectious disease and to clarify the resistance mechanisms of NTM.

摘要

为了更优化地治疗非结核分枝杆菌(NTM)感染,需要进一步研究分枝杆菌对抗菌药物的敏感性。共纳入 82 种 NTM 参考菌株和 23 种 NTM 临床分离株。采用阳离子调整 Mueller-Hinton 肉汤微量稀释法测定 41 种药物的最小抑菌浓度(MIC)。结果表明,大多数 NTM 对氨基糖苷类、喹诺酮类、三种大环内酯类(克拉霉素、阿奇霉素和罗红霉素)、头孢美唑、利奈唑胺和卷曲霉素敏感。快速生长分枝杆菌菌株还对头孢西丁、氯法齐明、利福喷汀、强力霉素、米诺环素、替加环素、美罗培南和磺胺甲噁唑敏感,而缓慢生长分枝杆菌菌株还对利福布汀敏感。这项关于 NTM 敏感性的研究包括了中国最大的临床分离株和参考菌株样本量。NTM 种特异性药物敏感性模式表明,迫切需要鉴定 NTM 的种类,规范 NTM 传染病的治疗,并阐明 NTM 的耐药机制。

相似文献

1
Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.中国临床分离株和非结核分枝杆菌参考株对 41 种药物的药敏性和 MIC 分布。
Int J Antimicrob Agents. 2017 Mar;49(3):364-374. doi: 10.1016/j.ijantimicag.2016.10.024. Epub 2016 Dec 21.
2
Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.呼吸道常见临床相关非结核分枝杆菌分离株的抗菌药敏和最小抑菌浓度分布。
Ann Med. 2022 Dec;54(1):2500-2510. doi: 10.1080/07853890.2022.2121984.
3
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
4
Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria.新型苯并咪唑类药物 SPR719 对非结核分枝杆菌的药敏试验。
Antimicrob Agents Chemother. 2018 Oct 24;62(11). doi: 10.1128/AAC.01503-18. Print 2018 Nov.
5
Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China.氯法齐明对中国北京分离的非结核分枝杆菌的活性。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00072-18. Print 2018 Jul.
6
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.新型 GenoType NTM-DR 试剂盒用于非结核分枝杆菌耐药性分子检测的评估
J Antimicrob Chemother. 2017 Jun 1;72(6):1669-1677. doi: 10.1093/jac/dkx021.
7
[Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].[土耳其一家转诊医院肺部样本中常见的生长缓慢的非结核分枝杆菌及其药敏试验结果评估]
Mikrobiyol Bul. 2019 Jul;53(3):330-335. doi: 10.5578/mb.68091.
8
Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.采用 slomyco 测试系统对缓慢生长非结核分枝杆菌进行药物敏感性测试。
PLoS One. 2018 Sep 17;13(9):e0203108. doi: 10.1371/journal.pone.0203108. eCollection 2018.
9
Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.非结核分枝杆菌性眼部感染——脓肿分枝杆菌与马西利亚分枝杆菌临床及微生物学特征比较
PLoS One. 2015 Jan 12;10(1):e0116236. doi: 10.1371/journal.pone.0116236. eCollection 2015.
10
Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.来自希腊克里特岛患者的非结核分枝杆菌的临床意义和抗生素药敏性。
Future Microbiol. 2011 Sep;6(9):1099-109. doi: 10.2217/fmb.11.91.

引用本文的文献

1
Negligible clinical impact of subsequent non-tuberculous mycobacteria isolation during MDR/RR-TB treatment: a 9-year retrospective cohort study from Wenzhou, China.耐多药/利福平耐药结核病治疗期间后续非结核分枝杆菌分离的临床影响可忽略不计:来自中国温州的一项9年回顾性队列研究
BMC Infect Dis. 2025 Jul 24;25(1):942. doi: 10.1186/s12879-025-11336-0.
2
The antimicrobial activity of linezolid against unconventional pathogens.利奈唑胺对非传统病原体的抗菌活性。
PeerJ. 2025 Feb 12;13:e18825. doi: 10.7717/peerj.18825. eCollection 2025.
3
Case report: A rare case of meningoencephalitis caused by .
病例报告:一例由……引起的罕见脑膜脑炎病例。 (注:原文中“caused by”后面内容缺失)
Front Med (Lausanne). 2024 Oct 23;11:1416272. doi: 10.3389/fmed.2024.1416272. eCollection 2024.
4
Analysis of Clinical Isolation Characteristics of Nontuberculous Mycobacteria and Drug Sensitivity of Rapidly Growing Mycobacteria in the General Hospital of Guangzhou, China.广州市第一人民医院非结核分枝杆菌临床分离特征及快速生长分枝杆菌药敏分析
Infect Drug Resist. 2024 Sep 19;17:4079-4088. doi: 10.2147/IDR.S465468. eCollection 2024.
5
Screening, epidemic trends and drug sensitivity analysis of nontuberculous mycobacteria in a local area of China.中国某局部地区非结核分枝杆菌的筛查、流行趋势及药敏分析
Am J Transl Res. 2024 Jul 15;16(7):3298-3305. doi: 10.62347/MAJY5046. eCollection 2024.
6
Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in abscessus.二代氨甲基棒酸菌素的研发克服了脓肿固有外排。
Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2314101120. doi: 10.1073/pnas.2314101120. Epub 2024 Jan 2.
7
Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease.口服β-内酰胺类药物联合治疗鸟分枝杆菌复合体肺病。
J Infect Dis. 2024 Aug 16;230(2):e241-e246. doi: 10.1093/infdis/jiad591.
8
Effectiveness and safety of regimens containing linezolid for treatment of Mycobacterium abscessus pulmonary Disease.利奈唑胺方案治疗脓肿分枝杆菌肺病的有效性和安全性。
Ann Clin Microbiol Antimicrob. 2023 Dec 6;22(1):106. doi: 10.1186/s12941-023-00655-2.
9
Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022.2017-2022 年中国西南地区肺结核疑似患者中非结核分枝杆菌的流行病学。
Front Cell Infect Microbiol. 2023 Oct 31;13:1282902. doi: 10.3389/fcimb.2023.1282902. eCollection 2023.
10
The effect of new combinations of carbapenem-β-lactamase inhibitors for .碳青霉烯-β-内酰胺酶抑制剂新组合对 … 的影响。
Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0052823. doi: 10.1128/aac.00528-23. Epub 2023 Sep 6.